GlassScriptPhysician profile
Karen D Allen
NPI 1942200183
$13,271.63
in general payments reported to CMS, 2019-2025
73 companies · $2,689 in 2025
The $2,689 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,571 · 2020: $1,569 · 2021: $1,567 · 2022: $1,834 · 2023: $1,692 · 2024: $2,349 · 2025: $2,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,730.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,252.52 | 2019-2025 | Carvykti, Tecvayli, Rybrevant |
| Daiichi Sankyo INC. | $958.53 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Amgen INC. | $812.31 | 2019-2025 | Evenity, Nplate |
| E.R. Squibb & Sons, L.L.C. | $679.50 | 2019-2024 | Opdivo, Opdualag |
| Seagen INC. | $615.69 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Astrazeneca Pharmaceuticals LP | $609.62 | 2019-2025 | Tagrisso, Calquence, Enhertu |
| Blueprint Medicines Corporation | $539.62 | 2020-2025 | Ayvakit |
| Eisai INC. | $521.73 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $505.58 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Lilly USA, LLC | $396.25 | 2019-2025 | Taltz, Verzenio, Jaypirca |
| Takeda Pharmaceuticals U.S.A., INC. | $343.68 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
| Sobi, INC | $334.99 | 2022-2025 | |
| Exelixis INC. | $324.38 | 2019-2025 | Cabometyx |
| Pfizer INC. | $313.07 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $294.87 | 2019-2025 | Dupixent, Libtayo |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.